Obio Technology Shanghai Corp Ltd
SSE:688238
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
O
|
Obio Technology Shanghai Corp Ltd
SSE:688238
|
CN |
|
AGI Infra Ltd
BSE:539042
|
IN |
|
I
|
IGE + XAO SA
XBER:IXA
|
FR |
|
Biostar Microtech International Corp
TWSE:2399
|
TW |
|
MGIC Investment Corp
NYSE:MTG
|
US |
|
Anhui Zhongding Sealing Parts Co Ltd
SZSE:000887
|
CN |
|
Youngone Corp
KRX:111770
|
KR |
|
G
|
Goviex Uranium Inc
SWB:7GU
|
CA |
|
J
|
JKG Land Bhd
KLSE:JKGLAND
|
MY |
|
Manhattan Associates Inc
NASDAQ:MANH
|
US |
|
biOasis Technologies Inc
XTSX:BTI
|
CA |
|
Merchants Bancorp
NASDAQ:MBIN
|
US |
|
H
|
Hotel Property Investments Ltd
ASX:HPI
|
AU |
|
Summit Hotel Properties Inc
NYSE:INN
|
US |
|
X
|
Xiaomi Corp
SWB:3CP
|
CN |
|
Detection Technology Oyj
LSE:0CXE
|
FI |
Obio Technology Shanghai Corp Ltd
Obio Technology Shanghai Corp. Ltd. engages in biomedical basic research, gene therapy drug incubation, and clinical grade gene therapy virus vector CDMO service provision. The company is headquartered in Shanghai, Shanghai and currently employs 631 full-time employees. The company went IPO on 2022-03-22. The firm is mainly engaged in providing contract research organization (CRO) services such as gene therapy vector development and gene function research for the basic research of gene therapy, as well as contract research and development production organization (CDMO) services such as pharmaceutical research and clinical sample production for the research and development of gene drugs. The firm mainly conducts business in the European and American markets and the domestic market.
Obio Technology Shanghai Corp. Ltd. engages in biomedical basic research, gene therapy drug incubation, and clinical grade gene therapy virus vector CDMO service provision. The company is headquartered in Shanghai, Shanghai and currently employs 631 full-time employees. The company went IPO on 2022-03-22. The firm is mainly engaged in providing contract research organization (CRO) services such as gene therapy vector development and gene function research for the basic research of gene therapy, as well as contract research and development production organization (CDMO) services such as pharmaceutical research and clinical sample production for the research and development of gene drugs. The firm mainly conducts business in the European and American markets and the domestic market.
